Definition

What Is Tuberculosis?

Tuberculosis (TB) is a contagious bacterial infection caused by Mycobacterium tuberculosis, primarily affecting the lungs (pulmonary TB) but capable of infecting almost any organ (extrapulmonary TB). Spread through airborne respiratory droplets, it remains one of the world's deadliest infectious diseases, killing ~1.3 million annually worldwide.

Two distinct forms: Latent TB infection (LTBI), bacteria present but contained by immune system, asymptomatic, not contagious; affects ~25% of global population. Active TB disease, bacterial replication causes symptoms and is contagious; develops in ~5-10% of latent infections, especially when immunity is compromised. Treatment is essential and curative.

The major modern challenges are drug-resistant TB (MDR-TB, XDR-TB) requiring 18-24+ months of treatment, and reactivation in immunocompromised patients (HIV⁷, biologics, transplant recipients). Vitamin D deficiency, malnutrition, diabetes, and tobacco use significantly increase risk. New shorter regimens (4-month rifapentine-based) and oral drugs for resistant TB are transforming treatment.

⚠️ Public Health Importance: Active pulmonary TB is highly contagious, household contacts have 30%+ infection rate. If you have persistent cough >3 weeks, weight loss, night sweats, and risk factors (immigrant from high-prevalence area, healthcare worker, homeless, HIV+, prison), get tested. Treatment is free in most US public health departments.

Stages of TB

🌱 Latent TB Infection (LTBI)

Bacteria present but dormant. Positive TST or IGRA, normal CXR. Asymptomatic. NOT contagious. Treated to prevent reactivation¹ (3 months rifapentine/isoniazid; 4 months rifampin).

🌗 Active Pulmonary TB

Symptoms + CXR changes + positive cultures. Highly contagious. Requires 4-6 months treatment (4-drug initial then 2-drug continuation). Now possibly 4-month regimens.

🌑 Extrapulmonary / Drug-Resistant

Extrapulmonary: lymph nodes, bone, kidney, brain. MDR-TB: resistant to isoniazid + rifampin. XDR-TB: also resistant to fluoroquinolones + injectables. New oral regimens (bedaquiline-based) revolutionary.

Signs & Symptoms

Symptoms of Tuberculosis

Latent TB is asymptomatic. Active TB typically presents with chronic respiratory symptoms plus constitutional features. Often develops gradually over weeks-months.

🫁 Pulmonary Symptoms

🤧

Persistent Cough (>3 weeks)

Initially dry, becomes productive. Most characteristic symptom of pulmonary TB. Persistent cough beyond 3 weeks in at-risk individuals warrants TB testing.

🩸

Hemoptysis (Coughing Blood)

Streaks of blood common; large volume bleeding indicates cavitation. Classic finding but not universal. Always investigate persistent hemoptysis.

😣

Chest Pain

Pleuritic chest pain, worsened by breathing. May indicate pleural involvement, pleural effusion (TB pleurisy).

😮‍💨

Shortness of Breath

Late finding with extensive lung involvement. May indicate pleural effusion or advanced disease.

🌡️ Constitutional Symptoms

⚖️

Unexplained Weight Loss

"Consumption", TB's historical name. Significant unintentional weight loss. Combined with respiratory symptoms, strongly suggests TB or cancer.

🌙

Night Sweats

Drenching night sweats requiring change of clothes/bedding. Classic TB symptom. Also seen in lymphoma, other infections.

🌡️

Low-Grade Persistent Fever

Often in afternoons/evenings. May be subtle. Combined with night sweats and weight loss = classic TB triad.

😴

Profound Fatigue, Loss of Appetite

Chronic disabling fatigue. Anorexia. Develop slowly over weeks-months. Often dismissed until significant weight loss occurs.

Diagnosis

How TB Is Diagnosed

🔬 Latent TB Screening

🧪 IGRA (Interferon Gamma Release Assay)

Blood test (QuantiFERON-TB Gold, T-SPOT). Preferred over TST in BCG-vaccinated patients. Single visit. Highly specific.

🧪 TST (Tuberculin Skin Test / PPD)

Intradermal injection, read at 48-72 hours. Positive cutoffs vary by risk (5mm, 10mm, 15mm). False positive with BCG vaccination.

📡 Chest X-Ray (After Positive Test)

After positive TST/IGRA, rule out active TB. Normal CXR with positive test → latent TB. Abnormal CXR → workup for active disease.

📋 Risk Factor Screening

Country of origin, recent travel, contact with active TB, healthcare/prison work, HIV status, immunosuppressive therapy planned.

🔬 Active TB Diagnosis

📡 Chest Imaging

Upper lobe cavitation classic in adult reactivation. Lower lobe infiltrates, lymphadenopathy in primary TB. Miliary pattern in disseminated disease.

🦠 Sputum AFB Smear + Culture

3 morning sputum samples (or induced sputum). AFB stain, initial. Culture, gold standard but takes 6-8 weeks. Determines drug susceptibility.

🧬 Xpert MTB/RIF Assay

Rapid PCR. Detects MTB + rifampin resistance in 2 hours. Game-changing for TB diagnosis. Now standard worldwide.

🔬 Bronchoscopy (Selected)

When sputum non-diagnostic and high clinical suspicion. Bronchoalveolar lavage + biopsy. Also for extrapulmonary TB diagnosis.

Treatment Comparison

Holistic vs. Conventional Treatment

🌿 HOLISTIC

💊 CONVENTIONAL

🌿

Holistic / Functional Approach

ADJUNCT to conventional TB therapy. Nutrition critical, malnutrition is both cause and consequence of TB.

Active TB

REQUIRES antibiotic regimen, holistic alone is INSUFFICIENT and DANGEROUS

Nutrition Support

High-calorie, high-protein diet essential, malnutrition worsens outcomes

Vitamin D

Deficiency major risk factor for reactivation and progression. Supplement to optimize.

Prevention

Treat latent TB in at-risk individuals; address risk factors

Comprehensive Adjunctive Approach

Active TB MUST be treated with antibiotics, holistic alone is dangerous and contributes to drug resistance. Standard treatment is curative.
Aggressive nutritional support, TB causes severe cachexia. High-calorie (40-45 kcal/kg), high-protein (1.5-2g/kg) diet essential
Vitamin D optimization, deficiency strongly associated with TB risk and severity. Test 25-OH-D first and set the dose with your clinician. Dosing limits: the adult tolerable upper intake level is 4,000 IU/day. The Endocrine Society treats 30 ng/mL as sufficient and prefers 40–60 ng/mL; the Institute of Medicine sets sufficiency at 20 ng/mL. Anything above that needs a blood test and a clinician, not a self-directed dose. Vitamin D activated by sunlight may have direct antimycobacterial effects.
Multivitamin during treatment, TB and treatment cause multiple micronutrient deficiencies
Address malnutrition, protein-calorie malnutrition both cause and consequence of TB. Aggressive nutritional support improves treatment outcomes.
Zinc supplementation, often deficient in TB patients; supports immune function
Vitamin A, often deficient; may support recovery (under supervision)
Pyridoxine (B6)³ 25-50mg/day, REQUIRED with isoniazid to prevent peripheral neuropathy
Probiotics during/after antibiotics, restore microbiome diversity
NAC, emerging evidence as adjunct; antioxidant support during treatment
Quit smoking, smoking is major TB risk factor; worsens outcomes
Address diabetes, strong TB risk factor; control improves outcomes
HIV testing, every TB patient should be tested for HIV (and vice versa)
Latent TB treatment, for high-risk individuals to prevent active disease (3 months once-weekly rifapentine+INH, or 4 months daily rifampin)
Public health reporting, TB is reportable. Health departments provide free treatment, contact tracing, directly observed therapy².
Adherence support, directly observed therapy (DOT) increases cure rates; reduces resistance development

✅ Nutrition Is Critical: Active TB causes severe wasting⁵. Aggressive nutritional support, high calories, high protein, vitamin D, multivitamins, significantly improves treatment outcomes and reduces mortality. View nutrition as essential therapy, not optional support.

💊

Conventional / Medical Approach

Multi-drug antibiotic regimens. Latent: short courses. Active: 4-6 months. MDR-TB: new oral regimens.

Latent TB

3 months once-weekly INH + rifapentine (3HP) OR 4 months daily rifampin (4R)

Active Drug-Susceptible

Standard: 2 months RIPE (rifampin, isoniazid, pyrazinamide, ethambutol) + 4 months INH + rifampin

NEW Shorter Regimen

4 months total: 2 months rifapentine + INH + pyrazinamide + moxifloxacin, then 2 months continuation

MDR-TB / XDR-TB

BPaL (bedaquiline + pretomanid + linezolid), 6 months oral; revolutionary for resistant disease

Modern Treatment Regimens

Latent TB, 3HP regimen: 3 months once-weekly isoniazid + rifapentine. Most preferred regimen. ~90% completion rate.
Latent TB, 4R: 4 months daily rifampin. Alternative; fewer drug interactions than rifapentine.
Latent TB, 9H (older): 9 months daily isoniazid. Used less now due to long duration.
Active TB standard regimen: Intensive phase (2 months): isoniazid + rifampin + pyrazinamide + ethambutol (RIPE). Continuation phase (4 months): isoniazid + rifampin.
NEW 4-month regimen (drug-susceptible TB): rifapentine + isoniazid + pyrazinamide + moxifloxacin × 2 months, then rifapentine + isoniazid + moxifloxacin × 2 months. As effective as 6-month regimen.
Pyridoxine (B6) 25-50mg/day: required with isoniazid to prevent peripheral neuropathy
Directly observed therapy (DOT): clinic or video-based for high-risk patients; reduces relapse and resistance
MDR-TB: traditionally 18-24 months. NEW BPaL regimen (bedaquiline + pretomanid + linezolid), 6 months, oral, ~90% cure rate. Revolutionary.
XDR-TB and pre-XDR: BPaL or BPaLM (add moxifloxacin) per WHO 2022 guidelines
HIV co-infection: start ART early; manage drug-drug interactions with rifamycins
Liver function monitoring: TB drugs hepatotoxic⁴, monthly LFTs during treatment
Ethambutol eye exam: baseline and monthly vision testing, optic neuritis risk
Contact tracing: through public health; identify and screen close contacts
Isolation: until sputum smear-negative AND clinical improvement; ~2 weeks typically
BCG vaccination: used in high-prevalence countries (not US); modest efficacy against childhood TB meningitis

⚠️ Major Treatment Advances: The new 4-month regimen for drug-susceptible TB and BPaL/BPaLM for MDR-TB are transforming treatment. Talk to your TB specialist about these shorter, all-oral regimens. Adherence is critical, incomplete treatment drives drug resistance.

Nutritional Strategy

Diet for TB Recovery

High-calorie, high-protein, vitamin and mineral-rich diet. Severe wasting is hallmark of TB, aggressive nutrition is essential therapy.

✅ Prioritize:

🥚 High Protein (1.5-2g/kg)

Eggs, fish, poultry, dairy, legumes. Critical for tissue repair and immune function. Significantly higher than usual recommendations.

🍚 Calorie-Dense Foods

40-45 kcal/kg/day. Nuts, nut butters, olive oil, avocados, whole milk, ghee. Combat severe wasting characteristic of TB.

🥬 Vitamin A & Vitamin C Rich

Carrots, sweet potatoes, leafy greens, citrus, peppers, berries. Support immune function and mucosal integrity.

🐟 Fatty Fish (Vitamin D, Omega-3)

Wild salmon, sardines, mackerel. Provides vitamin D and anti-inflammatory omega-3. 2-3x weekly.

🍽️ Frequent Small Meals

5-6 meals/day. Better tolerance when appetite is poor. Maintains positive energy balance for weight gain.

❌ Avoid:

🚭 Tobacco

Major TB risk factor. Continuing during treatment worsens lung damage and outcomes. Quit at any time helps.

🥃 Alcohol

Severe interaction with TB drugs (especially isoniazid, rifampin), hepatotoxicity risk. Avoid entirely during treatment.

🍬 Empty Calories

When intake is limited, every calorie should be nutrient-dense. Avoid sodas, sweets in favor of high-quality calories.

🍔 Ultra-Processed Foods

Low nutrient density. Pro-inflammatory. Don't waste limited stomach capacity on processed foods.

💊 Tyramine-Rich Foods (with INH)

Isoniazid weakly inhibits MAO. Aged cheeses, cured meats, fermented foods can rarely trigger reactions. Significance debated.

Supplement Protocol

Evidence-Based Supplements

Pyridoxine (B6) is REQUIRED with isoniazid. Vitamin D, multivitamin, and zinc support recovery.

Supplement	Mechanism & Evidence	Suggested Dose	Timing	Notes
Pyridoxine (Vitamin B6), REQUIRED	Prevents isoniazid-induced peripheral neuropathy. STANDARD with all INH regimens.	25-50mg/day	With INH dose	NON-NEGOTIABLE with isoniazid. Higher dose (50-100mg) for diabetics, pregnant, malnourished.
Vitamin D3	Deficiency major risk factor for TB. May enhance immune response to mycobacteria.	Test 25-OH-D first and set the dose with your clinician (titrate to >40 ng/mL)	With fat meal	Correcting a deficiency may need a higher dose, decided by your clinician. Test baseline and 3 months.
Multivitamin (High Quality)	TB and treatment cause multiple micronutrient deficiencies. Broad-spectrum support.	1 quality multivitamin/day	With food	Choose one with adequate B-complex, fat-soluble vitamins.
Zinc	Often deficient in TB patients. Supports immune function. May improve treatment response.	15-30mg/day	With food	Don't exceed 30mg long-term. Cycle with copper supplementation if extended use.
Omega-3 (EPA/DHA)	Anti-inflammatory; supports weight maintenance. May reduce TB-related inflammation.	2,000-3,000mg/day	With fat meal	Continue during and after treatment.
Probiotics	Restore microbiome diversity disrupted by long antibiotic course. Support immune function.	10-30 billion CFU/day, multi-strain	With or without food	Continue throughout treatment and 2-3 months after.
N-Acetyl Cysteine (NAC)	Antioxidant. May enhance TB drug efficacy and reduce hepatotoxicity. Emerging evidence.	600-1,200mg/day	Divided doses	Some evidence as adjunctive in MDR-TB. Discuss with TB specialist.
Whey Protein / Protein Powder	Easy way to boost protein intake when appetite limited. Critical during severe wasting.	20-40g protein supplement/day	Between meals	Add to smoothies, foods. Compensates for poor appetite.

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed 26 August 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.⁸ Tuberculosis is curable, and the treatment is a full course of combination antibiotics taken for months. The single most important thing is completing it. Stopping early is how drug-resistant tuberculosis is created, and multidrug-resistant TB requires far longer, more toxic treatment with worse outcomes, for the patient and for everyone they subsequently infect. Nothing on this page treats tuberculosis, and there is no herbal alternative to consider. Two practical points that are genuinely nutritional. Pyridoxine (vitamin B6) is given alongside isoniazid to prevent peripheral neuropathy and is not optional. And TB causes severe wasting, so nutritional support during treatment is part of care rather than an add-on. Active pulmonary TB is contagious and notifiable; contact tracing protects the people around you.

On latent versus active disease: latent tuberculosis infection means the organism is present and contained, with no symptoms and no infectiousness, and is treated to prevent reactivation, commonly with three months of weekly rifapentine and isoniazid or four months of rifampicin. Active pulmonary tuberculosis is infectious and requires multidrug treatment, conventionally an intensive phase followed by a continuation phase. ↩
On adherence and resistance. Incomplete or irregular treatment selects for resistant organisms. Multidrug-resistant tuberculosis requires prolonged regimens with greater toxicity and lower cure rates, though newer all-oral regimens such as BPaL and BPaLM have substantially improved outcomes, and a trial-based analysis found them cost-saving for both patient and health system while cutting pill burden, PubMed 39890235. Directly observed therapy and other adherence support improve completion, and health departments provide treatment free of charge in many countries precisely because completion is a public health matter. ↩
On pyridoxine with isoniazid. Isoniazid interferes with vitamin B6 metabolism and causes peripheral neuropathy, and pyridoxine at around 25 to 50 mg daily is given routinely to prevent it, particularly in people with diabetes, HIV, alcohol use, malnutrition, kidney failure or pregnancy. This is a rare instance where a vitamin is part of the prescribed regimen rather than an optional extra. ↩
On hepatotoxicity: isoniazid, rifampicin and pyrazinamide are all potentially hepatotoxic, with isoniazid and rifampicin the main contributors, and liver function is monitored on a schedule with defined thresholds for pausing treatment, PubMed 41939271. Alcohol should be avoided, and new nausea, vomiting, abdominal pain, dark urine or jaundice during treatment should prompt immediate contact with the treating team rather than stopping tablets unilaterally. ↩
On nutrition and tuberculosis: active tuberculosis causes profound catabolism and wasting, and undernutrition is both a risk factor for progression from infection to disease and a predictor of poor outcome. Nutritional support during treatment improves weight gain and, in trial evidence from high-burden settings, has been associated with better outcomes and reduced incidence among household contacts. This is one of the clearer nutrition-infection relationships in medicine. ↩
On vitamin D: vitamin D has a plausible role in macrophage antimycobacterial activity and deficiency is common in tuberculosis. Pooling individual data from eight randomized trials, vitamin D did not change time to sputum culture conversion overall, PubMed 30728208. It did accelerate conversion in the subgroup with multidrug-resistant disease, though that estimate rests on small numbers and its confidence interval is extremely wide, and no effect appeared in drug-sensitive tuberculosis. This is a marker of how fast sputum clears, not a measure of cure. Correct deficiency; do not expect it to change the course of the disease. ↩
On who is most at risk: HIV co-infection is the strongest risk factor for progression, and everyone diagnosed with tuberculosis should be tested for HIV. Diabetes, silicosis, tumour-necrosis-factor inhibitors and other immunosuppressants, smoking, malnutrition and crowded living conditions all raise risk. Screening before starting immunosuppressive therapy is standard. ↩
National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic.